News

A super-charged Mech-X4 races around the world to defeat Traeger's beasts, and Ryan must make one of his toughest decisions yet: save his friend or save the world?
Patients in the US with the ultra-rare disease WHIM syndrome now have their first approved treatment, after X4 Pharma’s Xolremdi was given a green light by the FDA. Oral CXCR4 antagonist ...